NFKB1 and benign prostatic hyperplasia: Our data suggested that the phosphorylation as well as the transcriptional activity of NF-κB p65 in PBMCs of BPH patients was significantly restrained by 25-OH D treatment (Figures 2(a) and 2(b)).